NCT04014335: An ongoing trial by Ionis Pharmaceuticals, Inc.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 8 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04014335 |
|---|---|
| Title | An Open-Label Phase 2a Clinical Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Subjects With Primary IgA Nephropathy |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 4, 2019 |
| Completion date | Feb. 8, 2024 |
| Required reporting date | Feb. 8, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 3, 2026 |
| Days late | None |